中华医学杂志（英文版）2024，Vol.137Issue(10)：1190-1198,9.DOI:10.1097/CM9.0000000000002873
Tildrakizumab for moderate-to-severe plaque psoriasis in Chinese patients:A12-week randomized placebo-controlled phase Ⅲ trial with long-term extension
Tildrakizumab for moderate-to-severe plaque psoriasis in Chinese patients:A12-week randomized placebo-controlled phase Ⅲ trial with long-term extension
Chen Yu 1Weili Pan 2Zhongwei Tian 3Jinhua Xu 4Zhenghua Zhang 4Nan Yu 5Xinsuo Duan 6Shuping Guo 7Qing Sun 8Weiquan Li 9Juan Tao 10Songmei Geng 11Zhijun Liu 12Yuanyuan Yin 13Gang Wang 1Bin Yang 14Yunhua Deng 15Fuqiu Li 16Xiaojing Kang 17Mingye Bi 18Furen Zhang 19Yi Zhao20
作者信息
- 1. Department of Dermatology,Xijing Hospital,The Fourth Military Medical University,Xi'an,Shaanxi 710032,China
- 2. Department of Dermatology,Zhejiang Provincial People's Hospital,Hangzhou,Zhejiang 310014,China
- 3. Department of Dermatology,The First Affiliated Hospital of Xinxiang Medical College,Xinxiang,Henan 453100,China
- 4. Department of Dermatology,Huashan Hospital Affiliated to Fudan University,Shanghai 200040,China
- 5. Department of Dermatology,General Hospital of Ningxia Medical University,Yinchuan,Ningxia 750000,China
- 6. Department of Dermatology,Affiliated Hospital of Chengde Medical University,Chengde,Hebei 067000,China
- 7. Department of Dermatology,The First Hospital of Shanxi Medical University,Taiyuan,Shanxi 030001,China
- 8. Department of Dermatology,Qilu Hospital of Shandong University,Jinan,Shandong 250012,China
- 9. Department of Dermatology,Yuebei People's Hospital,Shaoguan,Guangdong 512026,China
- 10. Department of Dermatology,Union Hospital Tongji Medical Collage Huazhong University of Science and Technology,Wuhan,Hubei 430022,China
- 11. Department of Dermatology,The Second Affiliated Hospital of Xi'an Jiaotong University,Xi'an,Shaanxi 710004,China
- 12. Department of Dermatology and Venereal Diseases,The First Affiliated Hospital of University of South China,Hengyang,Hunan 421001,China
- 13. Shenzhen Kangzhe Biotechnology Co.,Ltd.,Shenzhen,Guangdong 518052,China
- 14. Department of Dermatology,Dermatology Hospital of Southern Medical University,Guangzhou,Guangdong 510091,China
- 15. Department of Dermatology,Tongji Hospital,Huazhong University of Science and Technology,Wuhan,Hubei 430030,China
- 16. Department of Dermatology,The Second Hospital of Jilin University,Changchun,Jilin 130041,China
- 17. Department of Dermatology,People's Hospital of Xinjiang Uygur Autonomous Region,Urumqi,Xinjiang 830001,China
- 18. Department of Dermatology,Wuxi People's Hospital of Wuxi City,Wuxi,Jiangsu 214023,China
- 19. Department of Dermatology,Shandong Provincial Hospital for Skin Diseases & Shandong Provincial Institute of Dermatology and Venereology,Shandong First Medical University &Shandong Academy of Medical Sciences,Jinan,Shandong 250022,China
- 20. Department of Dermatology,Beijing Tsinghua Changgung Hospital,Beijing 102218,China
- 折叠
摘要
关键词
Tildrakizumab/Interleukin 23/Plaque psoriasis/Chinese/Randomized controlled trialKey words
Tildrakizumab/Interleukin 23/Plaque psoriasis/Chinese/Randomized controlled trial引用本文复制引用
Chen Yu,Weili Pan,Zhongwei Tian,Jinhua Xu,Zhenghua Zhang,Nan Yu,Xinsuo Duan,Shuping Guo,Qing Sun,Weiquan Li,Juan Tao,Songmei Geng,Zhijun Liu,Yuanyuan Yin,Gang Wang,Bin Yang,Yunhua Deng,Fuqiu Li,Xiaojing Kang,Mingye Bi,Furen Zhang,Yi Zhao..Tildrakizumab for moderate-to-severe plaque psoriasis in Chinese patients:A12-week randomized placebo-controlled phase Ⅲ trial with long-term extension[J].中华医学杂志（英文版）,2024,137(10):1190-1198,9.
